Furosemide

Product NDC: 71872-7380
Requested package NDC: 71872-7380-1
11-digit product format: 718727380
Labeler code: 71872
Product ID: 71872-7380_58cc1e47-84e7-1353-e063-6394a90a6374
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FUROSEMIDE
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Medical Purchasing Solutions, LLC
Application: NDA018667
Marketing category: NDA
Marketing start: 2005-02-28
Substance: FUROSEMIDE
Active strength: 10 mg/mL
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018667-001	FUROSEMIDE	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP		1982-05-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N018667-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N018667-001	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018667-001	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018667-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018667-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018667-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018667-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018667-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018667-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018667-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018667-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018667-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018667-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018667-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018667-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018667-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018667-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018667-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018667-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018667-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018667-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018667-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018667-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018667-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018667-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018667-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018667-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018667-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018667-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018667-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018667-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018667-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018667-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018667-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018667-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018667-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018667-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018667-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018667-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018667-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N018667-001	AP	1	`f41ea6bd6efb…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Furosemide
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FUROSEMIDE	10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7LXU5N7ZO5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1719286	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
58cc1e38-6000-1489-e063-6394a90a5978	Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	Medical Purchasing Solutions, LLC	58cc1e38-6000-1489-e063-6394a90a5978	2026-08-11	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667 ndc (package): 71872-7380-1 ndc (product): 71872-7380 ndc11 (package): 71872738001
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	75d5611a-f9e0-1841-e053-2991aa0af415	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	71b48f4d-9936-448c-9e3a-33f1182e1039	2026-05-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Hospira, Inc.	39fd32f2-6bb7-4a65-d298-e48d26bc80c7	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	Hospira, Inc.	aaced7a8-c3d7-4d66-8c07-aa407b8b3f35	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650	2026-05-06	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	75d68f19-424c-109e-e053-2991aa0ac857	2024-01-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	7b9af6a4-e1da-eb95-e053-2991aa0a031d	2024-01-22	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
71872-7380-1	71872738001	1 VIAL, SINGLE-DOSE in 1 BAG (71872-7380-1) / 10 mL in 1 VIAL, SINGLE-DOSE	2026-08-11	No	No	Current